Lessons from the controversy over statins - Authors' reply.
Virginia Barbour states in her letter that, with respect to the submission to the Committee on Publication Ethics (COPE) in October, 2014, by a group of senior doctors and scientists, she had “recused myself because of a potential conflict of interest”. However, that is not strictly accurate; Barbou...
Main Authors: | Armitage, J, Baigent, C, Collins, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Safety and efficacy of statins - Authors' reply
by: Collins, R, et al.
Published: (2017) -
Statins and diabetes - Authors' reply
by: Kearney, P, et al.
Published: (2008) -
Statins and diabetes - Reply
by: Kearney, P, et al.
Published: (2008) -
Cholesterol, statins, and mortality - Authors' reply
by: Lewington, S, et al.
Published: (2008) -
Misrepresentation of statin safety evidence.
by: Armitage, J, et al.
Published: (2014)